If that be the case, Why did they not do the same PR, 2 years back. It seams like the last two PR is for JPM conference. They don't have to preannounce the quarterly result as they would have waited for the conference to be over or they would have announced as part of quarterly earnings. May be, Monday SC denial will help them as well for the conference.
RMB, Amarin pays for every press release that's picked up by a newsfeed. Regarding the press release, I don't understand the section that mentions ApoC-111-targeted injectables. Who or what is Berg talking about? Does this have anything to do with the LR-EtEPA patent?
Market Data 
Markets 
AI
